Acasti Pharma | ACST - Operating Expenses

Stock Price
3.75
Daily Change
0 0%
Monthly
3.31%
Yearly
17.92%
Q1 Forecast
3.54

Acasti Pharma reported $62.82M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Acasti Pharma USD 62.82M 59.73M Sep/2025
Addus HomeCare USD 329.36M 12.81M Sep/2025
Amarin USD 51.37M 14.6M Sep/2025
Cassava Sciences USD 11.86M 2.23M Sep/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Option Care Health USD 1.35B 17.13M Sep/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Tilray USD 237.52M 17.34M Sep/2025